Riskpilot← Back to searchSign inGet full accessWesterpharma Oy
OYActiveY-tunnus 3146365-7Orapihlajantie 12Retail sale of medical and orthopaedic goods · NACE 4774Est. 2020— employees
Revenue 2025
EUR 615K
+1% vs 2024
EBITDA margin
31.0%
+2% vs 2024
Equity ratio
96.5%
Financial strength
Net profit 2025
EUR 164K
+5% vs 2024
| Revenue | EUR 615K | +1% |
| EBITDA | EUR 191K | +2% |
| Net profit | EUR 164K | +5% |
| Total assets | EUR 681K | +21% |
| Equity | EUR 657K | +23% |
| Employees | — | — |
Legal name
Westerpharma Oy
Y-tunnus number
3146365-7
Legal form
Osakeyhtiö
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
6. heinäkuuta 2020
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on lääke- ja terveydenhoitoon liittyvien tuotteiden ja tarvikkeiden, kemikalio-, rohdos- ja ravintoainevalmisteiden sekä kosmetiikan vähittäis- ja tukkumyynti, tuonti, vienti ja valmistus, työvoiman sekä koneiden, laitteiden, kalusteiden, asuin- ja liikekiinteistöjen sekä huoneistojen vuokraus. Yhtiö voi myös omistaa ja hallita arvopapereita, kiinteää ja irtainta omaisuutta, ostaa ja myydä arvopapereita, ostaa ja myydä asunto- ja kiinteistöyhtiön osakkeita sekä asuin- ja liikekiinteistöjä. Yhtiön toimialaan kuuluu myös lääke- ja apteekkialaan liittyvä konsultointi, tuotekehitys, terveys- ja markkinointipalvelujen myynti sekä terveyden- ja sairaudenhoitopalvelujen tuottaminen.
Address
Orapihlajantie 12
Phone
+3580400273217
Email
sari.westermarck@apteekit.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 416 | 740 | 635 | 610 | 615 |
| Staff expenses | — | — | −0 | −0 | −0 |
| EBITDA | 106 | 218 | 197 | 187 | 191 |
| Depreciation & amort. | — | — | −0 | −0 | −0 |
| EBIT | 106 | 218 | 197 | 187 | 191 |
| Net financials | — | 0 | −0 | 7 | 14 |
| Profit before tax | 106 | 218 | 197 | 195 | 205 |
| Tax | 21 | 44 | 39 | 39 | 41 |
| Net profit | 85 | 175 | 158 | 156 | 164 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 148 | 309 | 459 | 561 | 681 |
| Equity | 112 | 278 | 413 | 536 | 657 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 37 | 31 | 46 | 25 | 24 |
| Total debt | 37 | 31 | 46 | 25 | 24 |
EBITDA margin
31.0%
This company
15.8%
Market median
+96% vs market
20212025
Equity ratio
96.5%
This company
38.2%
Market median
+153% vs market
20212025
Return on equity
25.0%
This company
18.4%
Market median
+36% vs market
20212025
Net profit margin
26.6%
This company
8.1%
Market median
+228% vs market
20212025
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
SR | Audit | 2020 | — | — |
TE Deputy auditor | Deputy auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Westerpharma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sari Marjaana Westermarck | Chief Executive Officer | 0 companies |
| Stefan Rolf Axel Wiklund | Audit | 0 companies |
| Tony Erik Hämäläinen | Deputy auditor | 0 companies |
| Werner Johannes Westermarck | Board of Directors | 0 companies |
| Roy Elias Westermarck | Board of Directors | 0 companies |
| Henrik Kristian Westermarck | Board of Directors | 0 companies |